Wellington Management Group LLP 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 10:34 am Sale | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 1,261,480 2.210% | -1,986,813 (-61.16%) | Filing |
| 2024-02-08 10:03 am Purchase | 2023-12-29 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 3,248,293 5.770% | 172,281 (+5.60%) | Filing |
| 2023-02-06 2:36 pm Sale | 2022-12-30 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 3,076,012 5.400% | -992,464 (-24.39%) | Filing |
| 2022-02-04 09:06 am Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 4,068,476 7.150% | 666,918 (+19.61%) | Filing |
| 2021-02-03 10:29 am Purchase | 2020-12-31 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 3,401,558 6.450% | 3,401,558 (New Position) | Filing |